These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6137087)

  • 1. [Pharmacoclinical study of oral butofilolol in arterial hypertension. Effects on heart rate, blood pressure and the renin-angiotensin system].
    Martinand A; Corvol P; Milliez P
    Therapie; 1983; 38(3):265-9. PubMed ID: 6137087
    [No Abstract]   [Full Text] [Related]  

  • 2. [Blocking of the renin-angiotensin-aldosterone system in the study and treatment of arterial hypertension].
    Villarreal H
    Arch Inst Cardiol Mex; 1983; 53(1):1-3. PubMed ID: 6135394
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of the acute hemodynamic effects of butofilolol in the arterial hypertensive patient. Comparison with propranolol and atenolol].
    Lekieffre J; Carre A
    Ann Cardiol Angeiol (Paris); 1984; 33(5):339-43. PubMed ID: 6148036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Short term treatment of essential arterial hypertension with atenolol: effect on the renin-angiotensin-aldosterone system and on hemodynamic parameters].
    Indovina I; Salerno L; Licata G; Pepe S; Custro N
    Clin Ter; 1983 Feb; 104(3):223-6. PubMed ID: 6861459
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of a short-term oral administration of trimepranol on plasma renin activity (author's transl)].
    Slabý A; Dosková M; Horký K; Urbánek J; Reiseauer R
    Sb Lek; 1975 Apr; 77(4):102-6. PubMed ID: 238277
    [No Abstract]   [Full Text] [Related]  

  • 6. [The central hemodynamics and renin-angiotensin-aldosterone system in servicemen with arterial hypertension who participated in battle actions].
    Rakov AL; Mareev VIu; Bagmet AD; Shlyk SV
    Voen Med Zh; 2000 May; 321(5):21-4. PubMed ID: 10860446
    [No Abstract]   [Full Text] [Related]  

  • 7. Blood concentrations and pharmacodynamic effects of SL 75212, a new beta-adrenoceptor antagonist, after oral and intravenous administration [proceedings].
    Bianchetti G; Gomeni R; Kilborn JR; Morselli PL; Taylor EA; Warrington SJ
    Br J Clin Pharmacol; 1979 Oct; 8(4):403P-404P. PubMed ID: 41556
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changes in sweating during exertion. Effects of beta-blocker treatment].
    Mallion JM; Benedetti C; Bittel R; Dimitriou R; De Gaudemaris R; Debru JL; Perdrix A; Dubois F
    Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1256-60. PubMed ID: 6151828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemodynamic correlates of selective beta 1 adrenergic receptor blockade by cordanum during hemiton monotherapy in children with primary arterial hypertension].
    Kapliev VA
    Pediatriia; 1988; (9):112. PubMed ID: 2904673
    [No Abstract]   [Full Text] [Related]  

  • 10. Antihypertensive pharmacological agents: beyond their lowering blood pressure effects.
    Miatello RM
    Cell Mol Biol (Noisy-le-grand); 2005 Nov; 51(6):521-3. PubMed ID: 16309575
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hormonal contribution to short-term variability of blood pressure in a renovascular hypertension model].
    Ponchon P; Elghozi JL
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1203-7. PubMed ID: 8572874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure reduction is not the only determinant of outcome.
    Sever PS; Poulter NR; Elliott WJ; Jonsson MC; Black HR; Sever PS; Poulter NR; Elliott WJ; Jonsson MC; Black HR
    Circulation; 2006 Jun; 113(23):2754-72; discussion 2773-4. PubMed ID: 16769926
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of tolamolol and bufuralol on the arterial blood pressure and plasma renin activity. Contribution to the study of beta-blocking agents action mechanisms (author's transl)].
    Rostan A
    Schweiz Rundsch Med Prax; 1978 Jan; 67(1):27-35. PubMed ID: 23523
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma renin activity after the use of a new beta-adrenergic blocking agent (I.C.I. 66,032).
    Aberg H
    Int J Clin Pharmacol; 1974 Mar; 9(2):98-100. PubMed ID: 4151244
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of amlodipine and the combination of amlodipine and enalapril on the renin-angiotensin-aldosterone system in the dog.
    Atkins CE; Rausch WP; Gardner SY; Defrancesco TC; Keene BW; Levine JF
    J Vet Pharmacol Ther; 2007 Oct; 30(5):394-400. PubMed ID: 17803730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic effects of inhibitors of the renin-angiotensin system.
    Fouad-Tarazi FM
    J Hypertens Suppl; 1994 Jul; 12(2):S25-9. PubMed ID: 7965262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The pharmacodynamic and hypotensive efficacy of proxodolol in an acute drug test on hypertension patients].
    Kukes VG; Starodubtsev AK; Smirnov MV; Petrov IN
    Eksp Klin Farmakol; 1994; 57(3):45-7. PubMed ID: 7914120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The acute and chronic effects of betaxolol on blood pressure, renin-aldosterone, and renal function in essential hypertension.
    Reams GP; Bauer JH; Lau A
    J Clin Pharmacol; 1987 Feb; 27(2):118-21. PubMed ID: 2890665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological mechanism of angiotensin II receptor antagonists: implications for the treatment of elevated systolic blood pressure.
    Brooks DP; Ruffolo RR
    J Hypertens Suppl; 1999 Jun; 17(2):S27-32. PubMed ID: 10465064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordant effects of beta-blockade on central aortic systolic and brachial systolic blood pressure: considerations beyond the cuff.
    Epstein BJ; Anderson S
    Pharmacotherapy; 2007 Sep; 27(9):1322-33. PubMed ID: 17723086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.